Company Description
Elan has brains on its mind. The company is focused on the development of pharmaceuticals for neurological and autoimmune diseases, as well as for...
Key Elan Financials
| Company Type | Public - NYSE: ELN; Irish: ELA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $759.4 |
| 2006 Employees | 1,734 |
More Elan Financials (11 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Elan's competition across multiple industries
Top Elan Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Elan Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Kyran McLaughlin | Network | E-mail |
| President, CEO, and Director | G. Kelly Martin | Network | E-mail |
| EVP, CFO, and Director | Shane M. Cooke | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Elan News
- Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide... [U.S. Patents] (01 Jul 2008 13:22:00 EDT)
- Method for non-invasive wrinkle removal and skin treatment [U.S. Patents] (01 Jul 2008 13:19:00 EDT)
- Elan Corporation plc (ADR) (ELN) Corporate Event Announcement Notice [Wall Street Horizon] (26 Jun 2008 20:47:00 EDT)







